Ratain MJ - Search Results

1

Phase I clinical and pharmacokinetic study of oral 9-aminocamptothecin (NSC-603071).

Mani S, Iyer L, Janisch L, Wang X, Fleming GF, Schilsky RL, Ratain MJ. Mani S, et al. Among authors: ratain mj. Cancer Chemother Pharmacol. 1998;42(1):84-7. doi: 10.1007/s002800050789. Cancer Chemother Pharmacol. 1998. PMID: 9619763 Clinical Trial.

2

Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.

Schilsky RL, Ratain MJ. Schilsky RL, et al. Among authors: ratain mj. J Natl Cancer Inst. 1990 Sep 5;82(17):1411-5. doi: 10.1093/jnci/82.17.1411. J Natl Cancer Inst. 1990. PMID: 2388292

3

Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.

Schilsky RL, Janisch L, Berezin F, Mick R, Vogelzang NJ, Ratain MJ. Schilsky RL, et al. Among authors: ratain mj. Cancer Res. 1993 Mar 15;53(6):1293-6. Cancer Res. 1993. PMID: 7680282 Clinical Trial.

4

Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies.

Larson RA, Geller RB, Janisch L, Milton J, Grochow LB, Ratain MJ. Larson RA, et al. Among authors: ratain mj. Cancer Chemother Pharmacol. 1995;36(3):204-10. doi: 10.1007/BF00685847. Cancer Chemother Pharmacol. 1995. PMID: 7781139 Clinical Trial.

5

A phase I study of intermittent infusion cladribine in patients with solid tumors.

Kobayashi K, Vogelzang NJ, O'Brien SM, Schilsky RL, Vokes EE, Ratain MJ. Kobayashi K, et al. Among authors: ratain mj. Cancer. 1994 Jul 1;74(1):168-73. doi: 10.1002/1097-0142(19940701)74:1<168::aid-cncr2820740127>3.0.co;2-t. Cancer. 1994. PMID: 7911736 Clinical Trial.

6

Sequential therapy with dacarbazine and carmustine: a phase I study.

Mitchell RB, Dolan ME, Janisch L, Vogelzang NJ, Ratain MJ, Schilsky RL. Mitchell RB, et al. Among authors: ratain mj. Cancer Chemother Pharmacol. 1994;34(6):509-14. doi: 10.1007/BF00685663. Cancer Chemother Pharmacol. 1994. PMID: 7923562 Clinical Trial.

7

Prognostic factors for survival in patients treated in phase I clinical trials.

Janisch L, Mick R, Schilsky RL, Vogelzang NJ, O'Brien S, Kut M, Ratain MJ. Janisch L, et al. Among authors: ratain mj. Cancer. 1994 Oct 1;74(7):1965-73. doi: 10.1002/1097-0142(19941001)74:7<1965::aid-cncr2820740723>3.0.co;2-1. Cancer. 1994. PMID: 8082103

8

Modulation of vinblastine resistance with cyclosporine: a phase I study.

Samuels BL, Mick R, Vogelzang NJ, Williams SF, Schilsky RL, Safa AR, O'Brien SM, Ratain MJ. Samuels BL, et al. Among authors: ratain mj. Clin Pharmacol Ther. 1993 Oct;54(4):421-9. doi: 10.1038/clpt.1993.169. Clin Pharmacol Ther. 1993. PMID: 8222485 Clinical Trial.

9

Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456).

Vogelzang NJ, Mick R, Janisch L, Berezin F, Schilsky RL, Ratain MJ. Vogelzang NJ, et al. Among authors: ratain mj. Cancer Res. 1994 Jan 1;54(1):114-9. Cancer Res. 1994. PMID: 8261430 Clinical Trial.

10

Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.

Fleming GF, Ratain MJ, O'Brien SM, Schilsky RL, Hoffman PC, Richards JM, Vogelzang NJ, Kasunic DA, Earhart RH. Fleming GF, et al. Among authors: ratain mj. J Natl Cancer Inst. 1994 Mar 2;86(5):368-72. doi: 10.1093/jnci/86.5.368. J Natl Cancer Inst. 1994. PMID: 8308929 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters